Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 28, Issue 2, 2007, Pages 73-77

  Gisterek, Iwona ^a   Sedlaczek, Paweł ^a   Kornafel, Jan ^a   Harłoziñska Szmyrka, Antonina ^a   Łacko, Aleksandra ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGE; AGED; ANGIOGENESIS; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; PHARYNX CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PHARYNGEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847692326     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2006.06.015     Document Type: Article

References (26)

1. O-charoenrat P., Rhys-Evans P., and Eccles S.A. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92 (2001) 556-568
2. Chen Z., Malhotra P.S., Thomas G.R., et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5 (1999) 1369-1379
3. Eisma R.J., Jeffrey B.S., Spiro D., et al. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 174 (1997) 513-517
4. Kaya A., Ciledag A., Gulbay B.E., et al. The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients. Respir Med 98 (2004) 632-636
5. De Vita F., Orditura M., Lieto E., et al. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. Cancer 100 (2004) 270-278
6. Shang Z.J., Li J.R., and Li Z.B. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31 (2002) 495-498
7. Smith B.D., Haffty B.G., and Sasaki C.T. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance. Ann Otol Rhinol Laryngol 110 (2001) 221-228
8. Breier G. Functions of the VEGF/VEGF receptor system in the vascular system. Semin Thromb Hemost 26 (2000) 553-559
9. Michi Y., Morita I., Amagasa T., et al. Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncol 36 (2000) 81-88
10. Ferrara N. Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 9 (2004) 2-10
11. Barbera-Guillem E., Nyhus J.K., Wolford C.C., et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62 (2002) 7042-7049
12. Grutzkau A., Kruger-Krasagakes S., Baumeister H., et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 9 (1998) 875-884
13. Homer J.J., Anyanwu K., Ell S.R., et al. Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma. Clin Otolaryngol 24 (1999) 426-430
14. Harlozinska A., Sedlaczek P., Kulpa J., et al. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. Anticancer Res 24 (2004) 1149-1158
15. Dunst J., Stadler P., Becker A., et al. Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancer. Strahlenther Onkol 177 (2001) 469-473
16. Yamamoto Y., Toi M., Kondo S., et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Cancer Res 2 (1996) 821-826
17. Dirix L., Vermeulen P., Prove A., et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76 (1997) 238-243
18. Riedel F., Gotte K., Schwalb J., et al. Serum levels of vascular endothelial growth factor in patients with head and neck cancer. Eur Arch Otorhinolaryngol 257 (2000) 332-336
19. Chen Z., Malhotra P.S., Thomas G.R., et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5 (1999) 1369-1379
20. Rosen L.S. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control 9 (2002) 6-44
21. Shang Z.J., Li J.R., and Li Z.B. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31 (2002) 495-498
22. Ohta M., Konno H., Tanaka T., et al. The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett 192 (2003) 215-225
23. Werther K., Sorensen S., Christensen I.J., et al. Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer. Acta Oncol 42 (2003) 837-845
24. Nishimura R., Nagao K., Miyayama H., et al. Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer. Breast Cancer 10 (2003) 120-128
25. Karayiannakis A.J., Bolanaki H., Syrigos K.N., et al. Serum vascular endothelial growth factor levels in pancreatic cancer patients with advanced and metastatic disease and poor prognosis. Cancer Lett 194 (2003) 119-124
26. Dietz A., Rudat V., Vanselow B., et al. Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck. HNO 47 (1999) 695-701